Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant

Jinyan Liu, Abishek Chandrashekar, Daniel Sellers, Julia Barrett, Michelle Lifton, Katherine McMahan, Michaela Sciacca, Haley VanWyk, Cindy Wu, Jingyou Yu, Ai-ris Y. Collier, Dan H. Barouch
doi: https://doi.org/10.1101/2022.01.02.22268634

Article usage

Article usage: January 2022 to May 2025

AbstractFullPdf
Jan 2022203564099800
Feb 2022204424568
Mar 2022205017221
Apr 2022134615183
May 2022231616152
Jun 20222636793
Jul 20222826886
Aug 20221591665
Sep 2022548581
Oct 2022939176
Nov 20226733105
Dec 202291157
Jan 2023100457
Feb 202392536
Mar 202388438
Apr 202383240
May 202377132
Jun 202374516
Jul 202376427
Aug 2023691023
Sep 202374524
Oct 202387324
Nov 202384310
Dec 202349125
Jan 202460144
Feb 202444323
Mar 202433228
Apr 202439332
May 202440124
Jun 202455931
Jul 202426240
Aug 202447433
Sep 202450251
Oct 202442851
Nov 202436650
Dec 202438434
Jan 202546227
Feb 2025431425
Mar 2025681938
Apr 2025141522
May 202532318
Back to top
Posted January 03, 2022.
Download PDF
Data/Code
Email
Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant
Jinyan Liu, Abishek Chandrashekar, Daniel Sellers, Julia Barrett, Michelle Lifton, Katherine McMahan, Michaela Sciacca, Haley VanWyk, Cindy Wu, Jingyou Yu, Ai-ris Y. Collier, Dan H. Barouch
medRxiv 2022.01.02.22268634; doi: https://doi.org/10.1101/2022.01.02.22268634
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area